Gosselies, Belgium, Sep 30, 2024 –TheraVet today announces a strategic transformation project with H4Orphan aimed at creating a leader in idiopathic pulmonary fibrosis and accelerating the development of its multi-target drug candidate.
DOWNLOAD Theravet press release
